"10.1371_journal.pone.0043904","plos one","2012-08-24T00:00:00Z","Danko Georgiev; Guillermo González-Burgos; Mitsuru Kikuchi; Yoshio Minabe; David A Lewis; Takanori Hashimoto","Department of Psychiatry and Neurobiology, Kanazawa University Graduate School of Medical Science, Kanazawa, Ishikawa, Japan; Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America; Research Center for Child Mental Development, Kanazawa University, Kanazawa, Ishikawa, Japan; Department of Neuroscience, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America","Conceived and designed the experiments: DG DAL TH. Performed the experiments: DG. Analyzed the data: DG GGB MK YM DAL TH. Contributed reagents/materials/analysis tools: MK YM DAL TH. Wrote the paper: DG GGB MK YM DAL TH.","The authors have read the journals policy and have the following conflicts: DAL currently receives investigator-initiated research support from the National Institutes of Health, Commonwealth of Pennsylvania, Bristol-Myers Squibb, Curridium Ltd and Pfizer and in 2010–2012 served as a consultant in the areas of target identification and validation and new compound development to BioLine RX, Bristol-Myers Squibb, and Merck. TH served as a consultant for Ono Pharmaceutical Co., Ltd. in 2012. None of above funders was involved in the study design; collection, analysis, and interpretation of data; writing of the paper; or decision to submit for publication of this study. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2012","08","Danko Georgiev","DG",6,TRUE,3,1,6,6,TRUE,TRUE,FALSE,0,NA,FALSE
